Raymond James set a C$2.50 price objective on EnWave (CVE:ENW) in a research note released on Tuesday, BayStreet.CA reports. The brokerage currently has an outperform rating on the stock. Raymond James also issued estimates for EnWave’s Q1 2020 earnings at $0.00 EPS, Q2 2020 earnings at $0.00 EPS, Q3 2020 earnings at $0.00 EPS, Q4 2020 earnings at $0.01 EPS, FY2020 earnings at $0.01 EPS, Q1 2021 earnings at $0.01 EPS, Q2 2021 earnings at $0.01 EPS, Q3 2021 earnings at $0.02 EPS, Q4 2021 earnings at $0.02 EPS, FY2021 earnings at $0.06 EPS and FY2022 earnings at $0.09 EPS.
Separately, Cormark decreased their target price on shares of EnWave from C$2.60 to C$2.10 in a research report on Monday, December 16th.
Shares of CVE ENW opened at C$1.46 on Tuesday. The firm has a market cap of $162.47 million and a price-to-earnings ratio of -76.84. The stock’s fifty day moving average price is C$1.57 and its two-hundred day moving average price is C$1.89. EnWave has a one year low of C$1.42 and a one year high of C$2.66.
EnWave Company Profile
EnWave Corporation licenses, builds, and installs commercial-scale dehydration platforms for applications in the food, pharmaceutical, and industrial sectors to manufacturing companies in Canada. The company offers radiant energy vacuum (REV) dehydration platforms for food industry, such as nutraREV and quantaREV to dehydrate fruits and vegetables, cheese products, yogurt products, meat products, and snacks.
Further Reading: What is a capital gain?
Receive News & Ratings for EnWave Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EnWave and related companies with MarketBeat.com's FREE daily email newsletter.